The Motley Fool
20 Nov 2026, 09:50 UTC · 4h ago
Trulieve Was the First U.S. Pure-Play Cannabis Stock on the NYSE. Here's Which Stock Could Be Next.
Impact · against what's priced in
The article provides no new catalysts for TRLV or GTBIF, as the federal regulatory shift to Schedule III and the possibility of uplisting are already recognized. While GTBIF's financial strength makes it a viable candidate for an NYSE listing, the lack of a formal announcement means the market has already priced in its capability to do so.
- GTBIF+0.10
No priced-in read yet





